-
1 Comment
Phreesia, Inc is currently in a long term uptrend where the price is trading 22.9% above its 200 day moving average.
From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 14.7.
Phreesia, Inc's total revenue rose by 353.1% to $149M since the same quarter in the previous year.
Its net income has increased by 99.3% to $-27K since the same quarter in the previous year.
Finally, its free cash flow fell by 341.6% to $-8M since the same quarter in the previous year.
Based on the above factors, Phreesia, Inc gets an overall score of 4/5.
ISIN | US71944F1066 |
---|---|
Sector | Healthcare |
Industry | Health Information Services |
Exchange | NYSE |
CurrencyCode | USD |
Market Cap | 1B |
---|---|
PE Ratio | None |
Target Price | 31.7692 |
Beta | 0.82 |
Dividend Yield | None |
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients' mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare services clients, including single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies, as well as government entities and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PHR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025